InDex Pharmaceuticals Holding AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 97.51 million. Revenue was SEK 101.75 million compared to SEK 31.8 million a year ago. Net income was SEK 89.98 million compared to net loss of SEK 21.74 million a year ago. Basic earnings per share from continuing operations was SEK 0.17 compared to basic loss per share from continuing operations of SEK 0.04 a year ago.
For the six months, sales was SEK 97.51 million. Revenue was SEK 108.63 million compared to SEK 39.64 million a year ago. Net income was SEK 48.19 million compared to net loss of SEK 40.63 million a year ago. Basic earnings per share from continuing operations was SEK 0.09 compared to basic loss per share from continuing operations of SEK 0.08 a year ago.